P

Inventor

FITZGERALD KEVIN

US132 patents
⚠️ This page may combine multiple inventors who share the name “FITZGERALD KEVIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ALNYLAM PHARMACEUTICALS INC

24 patents
US7605251B2Oct 20, 2009

Compositions and methods for inhibiting expression of the PCSK9 gene

ALNYLAM PHARMACEUTICALS INC160 citations99
US10337010B2Jul 2, 2019

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC17 citations98
US9771591B2Sep 26, 2017

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC22 citations98
US9322018B2Apr 26, 2016

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC36 citations98
US11525138B2Dec 13, 2022

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC7 citations94
US11332743B2May 17, 2022

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC6 citations94
US11306314B2Apr 19, 2022

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC6 citations94
US11306315B2Apr 19, 2022

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC6 citations94
US11306316B2Apr 19, 2022

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC6 citations94
US10570393B2Feb 25, 2020

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC17 citations94
US10557139B2Feb 11, 2020

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC15 citations94
US10550390B2Feb 4, 2020

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC15 citations94
US9249415B2Feb 2, 2016

Complement component C5 iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC24 citations94
US11130953B2Sep 28, 2021

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC8 citations92
US9850488B2Dec 26, 2017

Complement component C5 iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC11 citations92
US9133461B2Sep 15, 2015

Compositions and methods for inhibiting expression of the ALAS1 gene

ALNYLAM PHARMACEUTICALS INC19 citations92
US11866709B2Jan 9, 2024

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC3 citations86
US11840692B2Dec 12, 2023

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC3 citations84
US11834662B2Dec 5, 2023

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC3 citations84
US11198872B2Dec 14, 2021

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC6 citations84
US11142766B2Oct 12, 2021

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC4 citations84
US11034958B2Jun 15, 2021

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC7 citations84
US10934545B2Mar 2, 2021

Angiopoietin-like 3 (ANGPTL3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC6 citations84
US10407679B2Sep 10, 2019

Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof

ALNYLAM PHARMACEUTICALS INC5 citations84

KMC PRODUCTS INC

13 patents

FITZGERALD KEVIN

3 patents

FAIRPLAY ELECTRIC CARS LLC

3 patents

RAJEEV KALLANTHOTTATHIL G

1 patent

(unassigned)

1 patent

TAN PAMELA

1 patent

KMC WHEEL COMPANY

1 patent

ZZYYXX CORP

1 patent

KMC ACQUISITION CORP

1 patent

KEY SAFETY SYSTEMS INC

1 patent

Showing the top 50 of 132 patents by PatentIndex Score.